Toyonaka, Japan

Hikaru Sonoda

This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignees: Shionogi Company Limited, Cosmo Bio Co., Ltd., Tohoku Techno Arch Co., Ltd.. Active years: 2008-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hikaru Sonoda. Retrieved from https://idiyas.com/inventor/hikaru-sonoda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 25.0

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Toyonaka, JP (2008 - 2011)
  • Osaka, JP (2013)
  • Settsu, JP (2016)

Company Filing History:


Years Active: 2008-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hikaru Sonoda - Innovator in Colorectal Cancer Detection

Introduction

Hikaru Sonoda is an inventor based in Sakai-shi, Osaka-fu, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. His innovative approach focuses on utilizing exosomes as biomarkers for early detection, which can potentially improve patient outcomes.

Latest Patent Applications

Hikaru Sonoda has developed a method for detecting colorectal cancer. This method involves measuring the amount of exosomes expressing CD147 in a body fluid sample derived from a test individual using an anti-CD147 monoclonal antibody or a fragment thereof. The process includes comparing the signal intensity of exosomes in the test individual with that of a control individual. A stronger signal intensity in the test individual indicates a higher likelihood of colorectal cancer presence. This method is valuable as it allows individuals to take preventive measures against cancer progression.

Conclusion

Hikaru Sonoda's work in colorectal cancer detection showcases the potential of innovative diagnostic methods in improving healthcare. His contributions may pave the way for more effective cancer screening techniques in the future.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…